US pediatric psychiatry under scrutinity for conflict of interest;La pédopsychiatrie américaine au ban des accusés

Medecine/Sciences

Volumn 25, Issue 5, 2009, Pages 534-536

  Chamak, Brigitte ^a  

^a CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

METHYLPHENIDATE; MIFEPRISTONE; PSYCHOTROPIC AGENT; RISPERIDONE; SEROTONIN;

ATTITUDE; AUTISM; BEHAVIOR; BIPOLAR DISORDER; CONSULTATION; DRUG INDUSTRY; DRUG USE; ECONOMICS; FOOD AND DRUG ADMINISTRATION; HEALTH CARE PERSONNEL; HUMAN; PARENT; PHYSICIAN; PRESCRIPTION; PSYCHIATRIST; SHORT SURVEY; UNITED STATES;

EID: 66849143705     PISSN: 07670974     EISSN: None     Source Type: Journal    
DOI: 10.1051/medsci/2009255534     Document Type: Short Survey

References (21)

1. Thomas CP, Conrad P, Casier R, Goodman E. Trends in the use of psychotropic medications among adolescent, 1994 to 2001. Psychiatric Services 2006 ; 57 : 63-69
2. Jensen PS, Bhatara VS, Vitiello B, et al. Psychoactive medication prescribing practices for US children: Gaps between research and clinical practice. J Am Acad Child Adolesc Psychiatry 1999 ; 38 : 557-565 (Pubitemid 29203471)
3. Olfson M, Blanco C, Liu L, et al. National trends in the outpatient treatment of children and adolescents with antipsychotic drugs. Arch Gen Psychiatry 2006 ; 63 : 679-685 (Pubitemid 43848299)
4. Ehrenberg A. L'individu incertain. Paris : Calmann-Lévy, 1995.
5. Ehrenberg A. La fatigue d'être soi. Paris : Odile Jacob, 1998.
6. Ehrenberg A. Les changements de la relation normal-pathologique. À propos de la souffrance psychique et de la santé mentale. Esprit 2004 ; 5 : 133-156
7. Kadison R. Getting an edge: use of stimulants and antidepressants in college. N Engl J Med 2005 ; 353 : 1089-1091 (Pubitemid 41317430)
8. Rose N. Neurochemical selves. Society 2003 ; 41 : 46-59. (Pubitemid 37489264)
9. Healy D. Shaping the intimate: influences on the experience of everyday nerves. Soc Stud Sci 2004 ; 34 : 219-245 (Pubitemid 38726847)
10. Kaiser J. Senate inquiry on research conflicts shifts to grantees. Science 2008 ; 320 : 1708.
11. Moreno C, Laje G, Blanco C, et al. National trends in the outpatient diagnosis and treatment of bipolar disorder in youth. Arch Gen Psychiatry 2007 ; 64 : 1032-1039 (Pubitemid 47360848)
12. Harris G, Carey B. Researchers fail to reveal full drug pay. The New York Times 8 juin 2008.
13. Carey B, Harris G. Psychiatric group faces scrutiny over drug industry ties. The New York Times 12 juillet 2008.
14. Perlis RH, Perlis CS, Wu Y, et al. Industry sponsorship and financial conflict of interest in the reporting of clinical trials in psychiatry. Am J Psychiat 2005 ; 162 : 1957-1960 (Pubitemid 41428627)
15. Dana J, Loewenstein G. A social science perspective on gifts to physicians from industry. JAMA 2003 ; 290 : 252-255 (Pubitemid 37430065)
16. Steinman MA, Shlipak MG, McPhee SJ. Of principles and pens: attitudes of medicine housestaff toward pharmaceutical industry promotions. Am J Med 2001 ; 110 : 551-557
17. Wazana A. Physicians and the pharmaceutical industry. Is a gift ever just a gift? JAMA 2000 ; 283 : 373-380
18. Turner EH, Matthews AM, Linardatos E, et al. Selective publication of antidepressant trials and its influence on apparent efficacy. N Engl J Med 2008 ; 358 : 252-260
19. Ehrenberg A. Santé mentale : malaise dans l'évaluation. Med Sci (Paris) 2006 ; 22 : 548-553
20. Chamak B. L'autisme n'est plus ce qu'il était. In : Champion F (sous la direction de). Psychothérapie et société. Paris : Armand Colin 2008 : 167-185
21. Ehrenberg A. Les changements de la relation normal-pathologique. À propos de la souffrance psychique et de la santé mentale. Esprit 2004 ; 5 : 133-156